Symbol="KRTX"
AssetType="Common Stock"
Name="Karuna Therapeutics Inc"
Description="Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts."
CIK="1771917"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="33 ARCH STREET, SUITE 3110, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="8001409000"
EBITDA="-338368992"
PERatio="None"
PEGRatio="None"
BookValue="39.79"
DividendPerShare="0"
DividendYield="0"
EPS="-9.43"
RevenuePerShareTTM="0.343"
ProfitMargin="0"
OperatingMarginTTM="-30.07"
ReturnOnAssetsTTM="-0.213"
ReturnOnEquityTTM="-0.325"
RevenueTTM="11291000"
GrossProfitTTM="10637000"
DilutedEPSTTM="-9.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.857"
AnalystTargetPrice="277.24"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.38"
PriceToBookRatio="5.94"
EVToRevenue="138.07"
EVToEBITDA="-25.22"
Beta="1.031"
num_52WeekHigh="278.25"
num_52WeekLow="122.59"
num_50DayMovingAverage="222.46"
num_200DayMovingAverage="207.81"
SharesOutstanding="37444000"
DividendDate="None"
ExDividendDate="None"
symbol="KRTX"
open="215.40"
high="217.10"
low="212.02"
price="213.69"
volume="225292.00"
latest_trading_day="2023-07-07"
previous_close="215.19"
change="-1.50"
change_percent="-0.6971%"
aroon_positive_momentum_days="45"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="45"
Volume_recent_avg="431992"
Change_recent_avg="0.25"
Delta_recent_avg="7.42"
Variance_recent_avg="3.71"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="45"
Aroon_momentum_negative="55"
image_negative_thumbnail_id_1="490"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0115.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="697"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_positive_thumbnail_id_2="959"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
